ACTRN12621000695808
Recruiting
未知
A Prospective Registry Study to Evaluate the Clinical Utility of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
Prelude Australia Pty Limited0 sites1,500 target enrollmentJune 7, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Ductal carcinoma in situ (DCIS) of the breast
- Sponsor
- Prelude Australia Pty Limited
- Enrollment
- 1500
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.A clinical decision has been made to order the DCISionRT™ Test as part of routine patient care
- •2\.Patient must have histologically confirmed ductal carcinoma in situ (DCIS) in a single breast (presence of lobular carcinoma in situ (LCIS) or other benign breast disease in addition to DCIS is acceptable)
- •3\.Patient must be consented within 120 days after surgery
- •4\.Patient must be eligible for, or have already received breast conserving surgery
- •5\.Patient must be eligible to receive radiation and/or systemic treatment
- •6\.Patient must be female and greater than 25 years old
- •7\.Patient must be able to provide informed consent
Exclusion Criteria
- •1\.Patient tissue is insufficient to generate DCISionRT test results or required DCISionRT inputs (age, tumor size, margin status, palpability) are missing
- •2\.Patient has invasive breast cancer or evidence in the ipsilateral or contralateral breast of invasive breast cancer, including microinvasion, lymph node involvement, or Paget’s disease of the nipple
- •3\.Patient has already been surgically treated with a mastectomy for primary DCIS
- •4\.Patient has prior in situ or invasive breast cancer
- •5\.Patient is pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of the clinical utility of the FebriDx® test for viral and bacterial upper respiratory infection in a UK A&E departmentISRCTN14380378niversity of Leeds908
Recruiting
Not Applicable
A prospective clinical registration study on the real world efficacy of Angong Niuhuang PillstrokeICD-10????:I64.04ITMCTR2200005593Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine
Completed
Not Applicable
Prospective registry study investigating medical care in hematooncologic patients with venousthromboembolism in BerliDRKS00008196Vivantes Klinikum im FriedrichshainKlinik für Innere Medizin/Angiologie , Funktionsbereich Hämostaseologie382
Recruiting
Phase 1
To see the clinical outcome of a restoration with a new tooth colored restoration in teeth with cavities rather than filling with silver collar restoratioHealth Condition 1: null- Healthy patients ,Age: 15 to 45 yearsPatients having good oral hygiene, posterior teeth requiring restoration for class II carious lesionCTRI/2018/02/011989ALL INDIA INSTITUTE OF MEDICAL SCIENCES NEW DELHI
Not yet recruiting
Not Applicable
Oligoprogressive treatment for immunotherapy patients (OPTION)ACTRN12623000653662Bendigo Health33